Alpharen (fermagate) / OPKO Health - LARVOL DELTA

Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials. (PubMed, Int Urol Nephrol) - "FC was associated with the control of hyperphosphatemia and the improvement of anemia. However, PA21 did not show superiority for alleviating anemia compared with the active treatment. Other IBPBs, such as fermagate and SBR759, remained poorly understood due to the limited number of studies. Further trials are required to assess the effect of IBPBs on the risk of cardiovascular events and all-cause mortality."

Journal • Retrospective data • Anemia • Cardiovascular • Hematological Disorders • Metabolic Disorders • Nephrology • Renal Disease